A PET Study: Single-dose, Open-label Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712.
Phase of Trial: Phase I
Latest Information Update: 31 May 2011
At a glance
- Drugs HT 0712 (Primary)
- Indications Cognition disorders
- Focus Pharmacodynamics; Pharmacokinetics
- 31 May 2011 Additional lead trial centre and company added as trial sponsor (Dart NeuroScience) as reported by ClinicalTrials.gov.
- 31 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Oct 2010 New trial record